JOSHUA SHAPIRO: Open Payments
NPI 1215995642 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,988 in 183 payments from 18 companies in 2025. Trend: 2023 $1,138 · 2024 $3,216 · 2025 $2,988
Food & beverage: $2,940Education: $48
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 41 | $434 |
| ABBVIE INC. | 20 | $385 |
| UCB, Inc. | 29 | $338 |
| Janssen Biotech, Inc. | 16 | $296 |
| PFIZER INC. | 19 | $241 |
| Botanix SB Inc | 11 | $224 |
| LEO Pharma Inc. | 17 | $202 |
| Cipher Pharmaceuticals US LLC | 1 | $180 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
Products named: Zoryve, Bimzelx, TREMFYA, SKYRIZI, SOFDRA, ADBRY, Natroba, DUPIXENT.
Industry payments across NY — which companies pay providers there.
